Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
CAR-T cells suffer from the disadvantage of insufficient persistence in vivo
Presented for research literature review only Van Someren EJ (2007)
But these will take years to get through proper testing and FDA approval
Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in Anyone who had problems with COVID vaccines (who seem like are generally in support of this) have any thoughts
US$ 24.01
US$ 22.09
US$ 27.31
US$ 21.37
US$ 22.99
US$ 23.84
